Literature DB >> 32773521

CORR Insights®: Targeted Muscle Reinnervation Improves Residual Limb Pain, Phantom Limb Pain, and Limb Function: A Prospective Study of 33 Major Limb Amputees.

Arvind D Nana1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32773521      PMCID： PMC7431261          DOI： 10.1097/CORR.0000000000001433

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.755


× No keyword cloud information.
  5 in total

1.  The use of targeted muscle reinnervation for improved myoelectric prosthesis control in a bilateral shoulder disarticulation amputee.

Authors:  T A Kuiken; G A Dumanian; R D Lipschutz; L A Miller; K A Stubblefield
Journal:  Prosthet Orthot Int       Date:  2004-12       Impact factor: 1.895

2.  Incidence and associations of painful neuroma in a contemporary cohort of lower-limb amputees.

Authors:  Anthony Penna; Alex H Konstantatos; William Cranwell; Eldho Paul; Francesco-Raffaele Bruscino-Raiola
Journal:  ANZ J Surg       Date:  2018-04-14       Impact factor: 1.872

3.  Gabapentin in postamputation phantom limb pain: a randomized, double-blind, placebo-controlled, cross-over study.

Authors:  Margaret Bone; Peter Critchley; Donal J Buggy
Journal:  Reg Anesth Pain Med       Date:  2002 Sep-Oct       Impact factor: 6.288

4.  Targeted muscle reinnervation for real-time myoelectric control of multifunction artificial arms.

Authors:  Todd A Kuiken; Guanglin Li; Blair A Lock; Robert D Lipschutz; Laura A Miller; Kathy A Stubblefield; Kevin B Englehart
Journal:  JAMA       Date:  2009-02-11       Impact factor: 56.272

5.  Targeted Muscle Reinnervation Improves Residual Limb Pain, Phantom Limb Pain, and Limb Function: A Prospective Study of 33 Major Limb Amputees.

Authors:  Lauren M Mioton; Gregory A Dumanian; Nikita Shah; Cecil S Qiu; William J Ertl; Benjamin K Potter; Jason M Souza; Ian L Valerio; Jason H Ko; Sumanas W Jordan
Journal:  Clin Orthop Relat Res       Date:  2020-09       Impact factor: 4.755
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.